Published in Biotech Business Week, January 3rd, 2005
DepoDur, which was approved by the U.S. Food & Drug Administration (FDA) on May 18, 2004, is SkyePharma's single dose sustained-release injectable formulation of morphine for the relief of pain after major surgery.
Endo is SkyePharma's licensee for DepoDur in North America.
SkyePharma PLC develops pharmaceutical products that provide easier-to-use drug formulations.
This article was prepared by Biotech Business Week...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.